237 related articles for article (PubMed ID: 33844613)
1. Antimicrobial peptides and other peptide-like therapeutics as promising candidates to combat SARS-CoV-2.
Mousavi Maleki MS; Rostamian M; Madanchi H
Expert Rev Anti Infect Ther; 2021 Oct; 19(10):1205-1217. PubMed ID: 33844613
[No Abstract] [Full Text] [Related]
2. Antimicrobial peptides: A promising tool to combat multidrug resistance in SARS CoV2 era.
Saini J; Kaur P; Malik N; Lakhawat SS; Sharma PK
Microbiol Res; 2022 Dec; 265():127206. PubMed ID: 36162150
[TBL] [Abstract][Full Text] [Related]
3. Peptides and peptidomimetics as a therapeutic candidate for the treatment of COVID-19: A brief review.
Kumaravel J; Singh H; Kaur S; Prakash A; Medhi B
Indian J Pharmacol; 2023; 55(1):53-58. PubMed ID: 36960521
[TBL] [Abstract][Full Text] [Related]
4. Promising role of defensins peptides as therapeutics to combat against viral infection.
Solanki SS; Singh P; Kashyap P; Sansi MS; Ali SA
Microb Pathog; 2021 Jun; 155():104930. PubMed ID: 33933603
[TBL] [Abstract][Full Text] [Related]
5. Human Antimicrobial Peptides as Therapeutics for Viral Infections.
Ahmed A; Siman-Tov G; Hall G; Bhalla N; Narayanan A
Viruses; 2019 Aug; 11(8):. PubMed ID: 31374901
[TBL] [Abstract][Full Text] [Related]
6. Compelling Evidence for the Activity of Antiviral Peptides against SARS-CoV-2.
Tonk M; Růžek D; Vilcinskas A
Viruses; 2021 May; 13(5):. PubMed ID: 34069206
[TBL] [Abstract][Full Text] [Related]
7. Antimicrobial peptides: A plausible approach for COVID-19 treatment.
Rani P; Kapoor B; Gulati M; Atanasov AG; Alzahrani Q; Gupta R
Expert Opin Drug Discov; 2022 May; 17(5):473-487. PubMed ID: 35255763
[TBL] [Abstract][Full Text] [Related]
8. Antiviral peptides against SARS-CoV-2: therapeutic targets, mechanistic antiviral activity, and efficient delivery.
Essa RZ; Wu YS; Batumalaie K; Sekar M; Poh CL
Pharmacol Rep; 2022 Dec; 74(6):1166-1181. PubMed ID: 36401119
[TBL] [Abstract][Full Text] [Related]
9. Peptides-based therapeutics: Emerging potential therapeutic agents for COVID-19.
Shah JN; Guo GQ; Krishnan A; Ramesh M; Katari NK; Shahbaaz M; Abdellattif MH; Singh SK; Dua K
Therapie; 2022; 77(3):319-328. PubMed ID: 34689960
[TBL] [Abstract][Full Text] [Related]
10. Comparative analysis of machine learning-based approaches for identifying therapeutic peptides targeting SARS-CoV-2.
Manavalan B; Basith S; Lee G
Brief Bioinform; 2022 Jan; 23(1):. PubMed ID: 34595489
[TBL] [Abstract][Full Text] [Related]
11. Potential of antiviral peptide-based SARS-CoV-2 inactivators to combat COVID-19.
Gurung AB; Ali MA; Lee J; El-Zaidy M; Aljowaie RM; Almutairi SM
PLoS One; 2022; 17(6):e0268919. PubMed ID: 35657783
[TBL] [Abstract][Full Text] [Related]
12. Gramicidin S and melittin: potential anti-viral therapeutic peptides to treat SARS-CoV-2 infection.
Enayathullah MG; Parekh Y; Banu S; Ram S; Nagaraj R; Kumar BK; Idris MM
Sci Rep; 2022 Mar; 12(1):3446. PubMed ID: 35236909
[TBL] [Abstract][Full Text] [Related]
13. Probing the competitive inhibitor efficacy of frog-skin alpha helical AMPs identified against ACE2 binding to SARS-CoV-2 S1 spike protein as therapeutic scaffold to prevent COVID-19.
Sekar PC; Srinivasan E; Chandrasekhar G; Paul DM; Sanjay G; Surya S; Kumar NSAR; Rajasekaran R
J Mol Model; 2022 Apr; 28(5):128. PubMed ID: 35461388
[TBL] [Abstract][Full Text] [Related]
14. COVID-19: Underpinning Research for Detection, Therapeutics, and Vaccines Development.
Aljabali AAA; Bakshi HA; Satija S; Metha M; Prasher P; Ennab RM; Chellappan DK; Gupta G; Negi P; Goyal R; Sharma A; Mishra V; Dureja H; Dua K; Tambuwala MM
Pharm Nanotechnol; 2020; 8(4):323-353. PubMed ID: 32811406
[TBL] [Abstract][Full Text] [Related]
15. Bioactive Molecules Derived from Snake Venoms with Therapeutic Potential for the Treatment of Thrombo-Cardiovascular Disorders Associated with COVID-19.
Chérifi F; Laraba-Djebari F
Protein J; 2021 Dec; 40(6):799-841. PubMed ID: 34499333
[TBL] [Abstract][Full Text] [Related]
16. Harnessing the Therapeutic Potential and Biological Activity of Antiviral Peptides.
Guarracino DA; Iannaccone J; Cabrera A; Kancharla S
Chembiochem; 2022 Oct; 23(20):e202200415. PubMed ID: 36075015
[TBL] [Abstract][Full Text] [Related]
17. Antimicrobial peptides: features, applications and the potential use against covid-19.
Mabrouk DM
Mol Biol Rep; 2022 Oct; 49(10):10039-10050. PubMed ID: 35606604
[TBL] [Abstract][Full Text] [Related]
18. AVPIden: a new scheme for identification and functional prediction of antiviral peptides based on machine learning approaches.
Pang Y; Yao L; Jhong JH; Wang Z; Lee TY
Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 34279599
[TBL] [Abstract][Full Text] [Related]
19. Antimicrobial peptides for novel antiviral strategies in the current post-COVID-19 pandemic.
Loffredo MR; Nencioni L; Mangoni ML; Casciaro B
J Pept Sci; 2024 Jan; 30(1):e3534. PubMed ID: 37501572
[TBL] [Abstract][Full Text] [Related]
20. Broad-Spectrum Antiviral Activity of the Amphibian Antimicrobial Peptide Temporin L and Its Analogs.
Zannella C; Chianese A; Palomba L; Marcocci ME; Bellavita R; Merlino F; Grieco P; Folliero V; De Filippis A; Mangoni M; Nencioni L; Franci G; Galdiero M
Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
